Trends

The Greek Innovation Fund: a new framework for access to innovative therapies

Learn how Greece's Innovation Fund is advancing earlier access to innovative therapies through a new market access framework.

Direct-to-employer drug models: From niche access model to channel strategy

Discover the market forces driving direct-to-employer adoption and what makes therapies strong candidates for direct commercialization.

Developing a direct-to-employer strategy for gross-to-net optimization

Learn how Acumetis evaluated a direct-to-employer strategy, identify partnership opportunities, and develop a roadmap to support GTN improvement and future commercialization decisions.

The “direct” continuum: Decoding direct-to-patient and direct-to-employer for commercial success

Explore how DTP and DTE models are reshaping commercialization, improving patient access, affordability, engagement, and market strategy.

Direct-to-patient access: Five questions pharma must answer

Direct-to-patient models are reshaping commercialization strategy. Explore key considerations around patient access, operational readiness, scalability, and DTP strategy in this Pharmaphorum interview with Acumetis.

From approval to patient access: How oncology pharmacy is shaping real-world delivery

Explore how oncology pharmacy services are shaping real-world delivery and patient access, and why operational readiness is critical beyond HTA approval.

Assessing payer ready economic model quality: Acumetis Model Builder vs AI

Can AI support HTA-ready economic models? Compare AI and Model Builder across reproducibility, transparency, and payer readiness.

Why direct-to-patient is not one-size-fits-all

Explore scalable direct-to-patient (DTP) models that improve affordability, time-to-therapy, and patient engagement with a strategic, data-driven approach.

Direct-to-patient (DTP) readiness assessment

We created a direct-to-patient (DTP) readiness assessment tool that distills complex market and patient dynamics into a clear readiness signal. This fact based tool enables you to assess your product...

Start the assessment now